Anna Wedell

695 total citations
28 papers, 498 citations indexed

About

Anna Wedell is a scholar working on Molecular Biology, Clinical Biochemistry and Rheumatology. According to data from OpenAlex, Anna Wedell has authored 28 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 6 papers in Rheumatology. Recurrent topics in Anna Wedell's work include Metabolism and Genetic Disorders (13 papers), Genomics and Rare Diseases (6 papers) and Epilepsy research and treatment (5 papers). Anna Wedell is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Genomics and Rare Diseases (6 papers) and Epilepsy research and treatment (5 papers). Anna Wedell collaborates with scholars based in Sweden, Germany and United Kingdom. Anna Wedell's co-authors include Holger Luthman, Michela Barbaro, Anna Nordenström, Monica Jönsson, Agne Larsson, Astrid Thilén, Lars Hagenfeldt, K Naess, Rolf Wibom and Thomas Kucinski and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anna Wedell

26 papers receiving 479 citations

Peers

Anna Wedell
Ahmed Alfares Saudi Arabia
Marwan Nashabat Saudi Arabia
Natalie Hauser United States
Joan E. Pellegrino United States
Cynthia S. Gubbels United States
Deborah L. Renaud United States
Austin Larson United States
Aditi I Dagli United States
Ahmed Alfares Saudi Arabia
Anna Wedell
Citations per year, relative to Anna Wedell Anna Wedell (= 1×) peers Ahmed Alfares

Countries citing papers authored by Anna Wedell

Since Specialization
Citations

This map shows the geographic impact of Anna Wedell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wedell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wedell more than expected).

Fields of papers citing papers by Anna Wedell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wedell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wedell. The network helps show where Anna Wedell may publish in the future.

Co-authorship network of co-authors of Anna Wedell

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wedell. A scholar is included among the top collaborators of Anna Wedell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wedell. Anna Wedell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Vivek, David J. Moore, Florian A. Rosenberger, et al.. (2025). The mitochondrial methylation potential gates mitoribosome assembly. Nature Communications. 16(1). 5388–5388. 2 indexed citations
2.
Bruhn, Helene, K Naess, Sofia Ygberg, et al.. (2024). Novel Synonymous and Deep Intronic Variants Causing Primary and Secondary Pyruvate Dehydrogenase Complex Deficiency. Human Mutation. 2024. 1–16. 1 indexed citations
3.
Naess, K, Albert Z. Lim, Robert McFarland, et al.. (2024). Quantitative proteomics of patient fibroblasts reveal biomarkers and diagnostic signatures of mitochondrial disease. JCI Insight. 9(20). 3 indexed citations
4.
Rosenberger, Florian A., Kai Chang, Fynn M. Hansen, et al.. (2024). Preventing excessive autophagy protects from the pathology of mtDNA mutations in Drosophila melanogaster. Nature Communications. 15(1). 10719–10719. 3 indexed citations
6.
Rasi, Chiara, Daniel Nilsson, Måns Magnusson, et al.. (2022). PatientMatcher: A customizable Python‐based open‐source tool for matching undiagnosed rare disease patients via the Matchmaker Exchange network. Human Mutation. 43(6). 708–716. 5 indexed citations
7.
Sørensen, L., et al.. (2022). Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism. The Journal of Pediatrics. 256. 38–43.e3. 7 indexed citations
8.
Ekwall, Olov, Mikael Sundin, Nicholas Brodszki, et al.. (2021). First Year of TREC-Based National SCID Screening in Sweden. International Journal of Neonatal Screening. 7(3). 59–59. 17 indexed citations
9.
Sørensen, L., Ulrika von Döbeln, Henrik Åhlman, et al.. (2020). Expanded Screening of One Million Swedish Babies with R4S and CLIR for Post-Analytical Evaluation of Data. International Journal of Neonatal Screening. 6(2). 42–42. 15 indexed citations
10.
Magnusson, Måns, Jesper Eisfeldt, Daniel Nilsson, et al.. (2020). Loqusdb: added value of an observations database of local genomic variation. BMC Bioinformatics. 21(1). 273–273. 5 indexed citations
11.
Ohlsson, Annika, Mary C. Hunt, Anna Wedell, & Ulrika von Döbeln. (2019). Heterogeneity of disease‐causing variants in the Swedish galactosemia population: Identification of 16 novel GALT variants. Journal of Inherited Metabolic Disease. 42(5). 1008–1018. 3 indexed citations
12.
Ohlsson, Annika, Helene Bruhn, Anna Nordenström, et al.. (2016). The Spectrum of PAH Mutations and Increase of Milder Forms of Phenylketonuria in Sweden During 1965–2014. JIMD Reports. 34. 19–26. 10 indexed citations
13.
Ygberg, Sofia, K Naess, Mats Eriksson, et al.. (2016). Biotin and Thiamine Responsive Basal Ganglia Disease – A vital differential diagnosis in infants with severe encephalopathy. European Journal of Paediatric Neurology. 20(3). 457–461. 17 indexed citations
14.
Dahlin, Maria, et al.. (2015). The ketogenic diet compensates forAGC1 deficiency and improves myelination. Epilepsia. 56(11). e176–81. 34 indexed citations
15.
Wibom, Rolf, Francesco M. Lasorsa, Virpi Töhönen, et al.. (2009). AGC1 Deficiency Associated with Global Cerebral Hypomyelination. New England Journal of Medicine. 361(5). 489–495. 134 indexed citations
16.
Nordenström, Anna, Astrid Thilén, Lars Hagenfeldt, Agne Larsson, & Anna Wedell. (1999). Genotyping Is a Valuable Diagnostic Complement to Neonatal Screening for Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency1. The Journal of Clinical Endocrinology & Metabolism. 84(5). 1505–1509. 86 indexed citations
17.
Kjellman, Magnus, Mikael Holst, Martin Bäckdahl, et al.. (1999). No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours. Clinical Endocrinology. 50(3). 343–346. 21 indexed citations
18.
Wedell, Anna, et al.. (1994). Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency. Human Genetics. 94(1). 50–54. 51 indexed citations
19.
Knoop, M., Jan M. Langrehr, V. König, et al.. (1994). Incidence and clinical relevance of recurrent hepatitis C infection after orthotopic liver transplantation. Transplant International. 7(s1). 221–223. 2 indexed citations
20.
Wedell, Anna, Chun Xu, & Holger Luthman. (1994). A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the Swedish population. Human Genetics. 93(2). 204–6. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026